Superconductor Technologies EBITDA margin
Quel est le EBITDA margin de Superconductor Technologies?
Le EBITDA margin de Superconductor Technologies Inc. est -1,472.55%
Quelle est la définition de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin des entreprises dans Technology secteur sur NASDAQ par rapport à Superconductor Technologies
Entreprises avec ebitda margin similaire à Superconductor Technologies
- Cullen Resources a EBITDA margin de -1,487.03%
- TALI Digital a EBITDA margin de -1,481.92%
- Cyprium Metals a EBITDA margin de -1,479.01%
- Sharing Economy International I a EBITDA margin de -1,477.42%
- Tortoise Infrastructure Corp a EBITDA margin de -1,475.23%
- Intra-Cellular Therapies Inc a EBITDA margin de -1,473.56%
- Superconductor Technologies a EBITDA margin de -1,472.55%
- Faster Enterprises a EBITDA margin de -1,469.20%
- NICO Resources Ltd a EBITDA margin de -1,465.21%
- Neovasc Inc a EBITDA margin de -1,458.22%
- Condor Petroleum a EBITDA margin de -1,456.70%
- Nikola a EBITDA margin de -1,434.15%
- Fate Therapeutics Inc a EBITDA margin de -1,431.66%